NRG Therapeutics
A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
About
NRG Therapeutics is a biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of neurodegenerative diseases such as Parkinson's and Alzheimer's. Their approach centers on restoring mitochondrial function, a key factor in the progression of these debilitating conditions. Teams look it up for Biotech, MedTech, Drug Discovery.
Frequently asked
What does NRG Therapeutics do?
NRG Therapeutics is a Biotech company that offers Software. Teams look it up for MedTech, Drug Discovery, Neurodegenerative Diseases. It is based in Stevenage, United Kingdom. Public records show about 23 people and $59M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has NRG Therapeutics raised?
NRG Therapeutics has raised a total of $59M in funding. The most recent round on record is Series B.
Where is NRG Therapeutics headquartered?
NRG Therapeutics is headquartered in Stevenage, United Kingdom.
What industry does NRG Therapeutics operate in?
NRG Therapeutics operates in Biotech, MedTech, Drug Discovery, Neurodegenerative Diseases, Mitochondrial Dysfunction.
How many employees does NRG Therapeutics have?
NRG Therapeutics has approximately 23 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.